Autism traits in the RASopathies
- PMID: 24101678
- PMCID: PMC4230531
- DOI: 10.1136/jmedgenet-2013-101951
Autism traits in the RASopathies
Abstract
Background: Mutations in Ras/mitogen-activated protein kinase (Ras/MAPK) pathway genes lead to a class of disorders known as RASopathies, including neurofibromatosis type 1 (NF1), Noonan syndrome (NS), Costello syndrome (CS), and cardio-facio-cutaneous syndrome (CFC). Previous work has suggested potential genetic and phenotypic overlap between dysregulation of Ras/MAPK signalling and autism spectrum disorders (ASD). Although the literature offers conflicting evidence for association of NF1 and autism, there has been no systematic evaluation of autism traits in the RASopathies as a class to support a role for germline Ras/MAPK activation in ASDs.
Methods: We examined the association of autism traits with NF1, NS, CS and CFC, comparing affected probands with unaffected sibling controls and subjects with idiopathic ASDs using the qualitative Social Communication Questionnaire (SCQ) and the quantitative Social Responsiveness Scale (SRS).
Results: Each of the four major RASopathies showed evidence for increased qualitative and quantitative autism traits compared with sibling controls. Further, each RASopathy exhibited a distinct distribution of quantitative social impairment. Levels of social responsiveness show some evidence of correlation between sibling pairs, and autism-like impairment showed a male bias similar to idiopathic ASDs.
Conclusions: Higher prevalence and severity of autism traits in RASopathies compared to unaffected siblings suggests that dysregulation of Ras/MAPK signalling during development may be implicated in ASD risk. Evidence for sex bias and potential sibling correlation suggests that autism traits in the RASopathies share characteristics with autism traits in the general population and clinical ASD population and can shed light on idiopathic ASDs.
Keywords: Autism; Costello Syndrome; Cranio-Facio-Cutaneous Syndrome; Neurofibromatosis Type 1; Noonan Syndrome.
Conflict of interest statement
Figures
Similar articles
-
Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway.Am J Med Genet A. 2016 Oct;170(10):2570-7. doi: 10.1002/ajmg.a.37736. Epub 2016 May 7. Am J Med Genet A. 2016. PMID: 27155212
-
Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.Arch Argent Pediatr. 2019 Oct 1;117(5):330-337. doi: 10.5546/aap.2019.eng.330. Arch Argent Pediatr. 2019. PMID: 31560489 English, Spanish.
-
Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.Endocr Regul. 2013 Oct;47(4):217-22. doi: 10.4149/endo_2013_04_217. Endocr Regul. 2013. PMID: 24156711 Review.
-
Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.Am J Med Genet A. 2017 Sep;173(9):2346-2352. doi: 10.1002/ajmg.a.38337. Epub 2017 Jun 26. Am J Med Genet A. 2017. PMID: 28650561
-
Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome.Am J Med Genet A. 2014 Nov;164A(11):2814-21. doi: 10.1002/ajmg.a.36737. Epub 2014 Sep 22. Am J Med Genet A. 2014. PMID: 25250515 Review.
Cited by
-
Non-Mammalian Models for Understanding Neurological Defects in RASopathies.Biomedicines. 2024 Apr 10;12(4):841. doi: 10.3390/biomedicines12040841. Biomedicines. 2024. PMID: 38672195 Free PMC article. Review.
-
Exploring key genes and pathways associated with sex differences in autism spectrum disorder: integrated bioinformatic analysis.Mamm Genome. 2024 Jun;35(2):280-295. doi: 10.1007/s00335-024-10036-5. Epub 2024 Apr 9. Mamm Genome. 2024. PMID: 38594551
-
Autism spectrum disorder profiles in RASopathies: A systematic review.Mol Genet Genomic Med. 2024 Apr;12(4):e2428. doi: 10.1002/mgg3.2428. Mol Genet Genomic Med. 2024. PMID: 38581124 Free PMC article. Review.
-
Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.Orphanet J Rare Dis. 2024 Mar 12;19(1):115. doi: 10.1186/s13023-024-03093-1. Orphanet J Rare Dis. 2024. PMID: 38475852 Free PMC article.
-
Surgical revascularization as a procedure to prevent neurological complications in children with moyamoya syndrome associated with neurofibromatosis I: a single institution case series.Childs Nerv Syst. 2024 Jun;40(6):1731-1741. doi: 10.1007/s00381-024-06304-z. Epub 2024 Feb 6. Childs Nerv Syst. 2024. PMID: 38316674 Free PMC article.
References
-
- Blumberg S, Bramlett M, Kogan MD, Schieve L, Jones J, Lu M. Changes in Prevalence of Parent-reported Autism Spectrum Disorder in School-Aged U.S. Children: 2007 to 2011–2012. CDC National Health and Statistics Reports. 2013 - PubMed
-
- Baio J. Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, 14 sites, United States, 2008. Morb Mortal Wkly Rep. 2012;61:1–19. - PubMed
-
- Carter MT, Scherer SW. Autism spectrum disorder in the genetics clinic: a review. Clin Genet. 2013;83:399–407. - PubMed
-
- Zafeiriou DI, Ververi A, Dafoulis V, Kalyva E, Vargiami E. Autism spectrum disorders: the quest for genetic syndromes. Am J Med Genet. 2013;162B:327–66. - PubMed
-
- Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, Yamrom B, Lee Y-H, Narzisi G, Leotta A, Kendall J, Grabowska E, Ma B, Marks S, Rodgers L, Stepansky A, Troge J, Andrews P, Bekritsky M, Pradhan K, Ghiban E, Kramer M, Parla J, Demeter R, Fulton LL, Fulton RS, Magrini VJ, Ye K, Darnell JC, Darnell RB, Mardis ER, Wilson RK, Schatz MC, McCombie WR, Wigler M. De novo gene disruptions in children on the autistic spectrum. Neuron. 2012;74:285–99. - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous